Navigation Links
Milli-Q Gradient A10 bench-integrated system

ProductsMilli-Q Gradient A10 bench-integrated system
Company Millipore
Item Milli-Q Gradient A10 bench-integrated system
Features Inquire
Description Millipore has developed a range of Milli-Q ultrapure water systems designed to match specific water quality requirements. Each of the five new Milli-Q systems is designed to specifically target contaminants detrimental to particular applications such as HPLC, molecular biology and ICP-MS. The systems incorporate a high precision resistivity monitor that records conductivity or resistivity (compensated or not to 25 C), and also feature a built-in TOC monitor with a 1 999 ppb detection range for accurate analysis of organics. Milli-Q systems meet USP 24 requirements for resistivity and TOC suitability tests. Validation and qualification services are available, and the optional Explore Data software allows easy access to historical data via a computer interface for documenting GLP compliance. All systems can be bench-operated, wall-mounted or bench-integrated for maximizing space requirements.

All systems in the Milli-Q range employ a 3-step purification process:
Step 1:
Plug-in Q-Gard purification packs are tailored to the feedwater source to optimize the performance of downstream purification media to ensure consistent results.
Step 2:
Quantum application-specific cartridges remove ionic and organic contaminants down to trace levels.
Step 3:
Final purification of ultrapure water is carried out at the point-of-use by a pharmaceutical-grade, absolute 0.22 m Millipak membrane filter that is recommended for most analytical applications.

The ultraviolet photo-oxidation process (UV at 254 and 185 nm) used in Milli-Q Gradient, Synthesis and Element Systems can effectively carry out the destruction of organic molecules, to reduce TOC levels to < 5 ppb, improving consistency and sensitivity in applications such as HPLC, IC, solid-phase extraction and UV spectroscopy.

Info Millipore
Customer Service: (978) 715-4321
Web site: http://www.millipore.com/

Related medicine products :

1. Milli-Q Gradient A10 System
2. Milli-Q Gradient System (non-TOC)
3. Milli-Q Gradient bench-integrated system (non-TOC)
4. Milli-Q Academic A10 bench-integrated system
5. Milli-Q Academic System (non-TOC)
6. Milli-Q Academic A10 System
7. Milli-Q Academic bench-integrated system (non-TOC)
8. Milli-Q Biocel A10 System
9. Milli-Q Biocel A10 bench-integrated system
10. Milli-Q Biocel System (non-TOC)
11. Milli-Q Biocel System bench-integrated system (non-TOC)
Siemens Webcast
Siemens Webcast: Legislative Developments Impacting Cardiology Services Reimbursement
...ny pH catheters are designed for patient comfort a...re number marked at 5cm intervals and line marked ...models are available spanning most clinical needs ...e models with one or two sensors., ,Flexilog sing...
...ny pH catheters are designed for patient comfort a...re number marked at 5cm intervals and line marked ...models are available spanning most clinical needs ...e models with one or two sensors., ,A range of fo...
Medicine Products:
(Date:11/27/2009)... , SAN FRANCISCO, Nov. 27 /PRNewswire-FirstCal...nounced that Blair Lambert, CFO/COO, will present ...l be held at the May Fair Hotel in London, England...T. ,, To listen to a live broadcast of The Gymb... please log on to www.gymboree.com, click on "Our ...
(Date:11/27/2009)... , NEUILLY-SUR-SEINE, France, Nov. 27 /PRNe...can professional cycling team dedicated to ethical...cling champions, announced today that it will beco...ansitions Optical as a new sponsor of the team. Tr...rer of adaptive eyewear, offering the most advance...
(Date:11/27/2009)... XenaCare Holdings has announ...rthritis Foundation, one of the largest nonprofit ...public health education. , ...naCare Holdings, Inc. (OTCBB: XCHO), a company spe... of consumer healthcare products, has announced to...
(Date:11/27/2009)...ing rates to bring unprecedented medical, economic.... 27 (HealthDay News) -- The number of people with...le over the next 25 years, a new study predicts. ,....1 million people with the disease, up from 23.7 m...treating people with diabetes will triple, the stu...
(Date:11/27/2009)... Voyant Health™ announc...gan) has licensed its TraumaCad Enterprise orthope...orkflow solution. , (PRWE...nced today that Spectrum Health (Grand Rapids, Mic...pedic templating solution and its TraumaCad Extend...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3
...ards, Find Inspiration in Video Blogs on,Determine...r,couple,s video blogs documenting their efforts t... Pennsylvania Department of Health,s new tobacco,c...to quit smoking together, not just for themselves,...
...eth Campaign to Eliminate Compounded Hormones, WA...mpounding Pharmacists (IACP) today called on the A...AACE) and the North American,Menopause Society (NA...nt. In recent weeks, AACE, NAMS and other supposed...
...dividuals or families may have underlying speech d...ews) -- People with a personal or family history o...rare type of dementia that causes them to lose lan... and progressively impaired, even though the perso...
...ith the recent announcement by,the United States F...ng,safety review of Botox Cosmetic (botulinum toxi...to treat frown lines between the brows. Botox(R),C... In its recent communication, the FDA reports adve...
...Healthcare Services,Inc. (NYSE: AHS ), the nation...oday that Hala Moddelmog, President and Chief Exec...joined the company,s Board of,Directors., "Hala b...ng president and strategic leader of a successful,...
... first PDP to conduct ePrescribing Pilot Study, F...s a bill that would tie physicians, Medicare payme... Health Solutions, Inc. (NYSE: MHS ) today,announ...escriptions. The pilot program will also be used t...
Other Medicine News:Health News:American Association of Clinical Endocrinologists and North American Menopause Society Fail to Disclose Financial Ties to Wyeth Pharmaceuticals 2Health News:Learning Disabilities May Presage Later Language Problems 2Health News:Botox Cosmetic Alternatives Are Available: Surgical Procedures Offer Solution for Wrinkles 2Health News:AMN Healthcare Appoints Hala Moddelmog to Its Board of Directors 2Health News:AMN Healthcare Appoints Hala Moddelmog to Its Board of Directors 3Health News:Medco Launches Medicare Part D Initiative to Promote ePrescribing 2Health News:Medco Launches Medicare Part D Initiative to Promote ePrescribing 3Health News:Medco Launches Medicare Part D Initiative to Promote ePrescribing 4
(Date:11/25/2009)...lif., Nov. 25 ChemoCentryx, Inc....from the Company,s PROTECT-1 (the Prospective Rand...Trial) of Traficet-EN(TM) (CCX282-B) in patients w...d clinical efficacy with a favorable safety and to...ce of clinical efficacy in the reduction of diseas...
(Date:11/24/2009)...Nov. 24 Endologix, Inc. ...treatments for aortic disorders, announced today t...all proceedings in, the patent infringement lawsui... The motion was filed in the United States Distri... has requested that the stay remain in effect whil...
(Date:11/24/2009)...24 Anadys Pharmaceutical...ill present at the 21st Annual Piper Jaffray Healt...:00 a.m. EST (6:00 a.m. PST). The conference is b...land, Ph.D., President and Chief Executive Officer... its clinical development programs, ANA598 and ANA...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Blood Tests May Spot Colon Cancer 58044 1Blood Tests May Spot Colon Cancer 58044 2Blood Tests May Spot Colon Cancer 58044 3Blood Tests May Spot Colon Cancer 58044 4Prix Galien USA to Launch a Health Care Dialogue Among World Leading Innovators in Science Economics and Biotech 58040 1Prix Galien USA to Launch a Health Care Dialogue Among World Leading Innovators in Science Economics and Biotech 58040 2SoluLinK Introduces Product that Links All Biomolecules Greater Than 20 Times Faster with 100 25 Yields 14215 1SoluLinK Introduces Product that Links All Biomolecules Greater Than 20 Times Faster with 100 25 Yields 14215 2